CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 15 | 326,786 | $11.92M |
| Grant or award | 8 | 70,311 | |
| Option exercise | 18 | 433,558 | |
| Tax withholding / forfeiture | 6 | 19,013 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
94 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Open-market sale | Common Stock | 20,000 | $46.29 | $926K | ||
| Open-market sale | Common Stock | 16,000 | $46.94 | $751K | ||
| Open-market sale | Common Stock | 2,188 | $46.15 | $101K | ||
| Open-market sale | Common Stock | 500 | $46.75 | $23K | ||
| Open-market sale | Common Stock | 44,700 | $47.06 | $2.10M | ||
| Tax withholding / forfeiture | Common Stock | 2,872 | $47.85 | $137K | ||
| John Walter Hanna Jr. - Officer | Option exercise | Common Stock | 118,000 | $8.20 | $968K | |
| John Walter Hanna Jr. - Officer | Open-market sale | Common Stock | 50,000 | $36.11 | $1.81M | |
| John Walter Hanna Jr. - Officer | Open-market sale | Common Stock | 68,000 | $39.01 | $2.65M | |
| John Walter Hanna Jr. - Officer | Option exercise | Employee Stock Option (Right to Buy) | 118,000 | $0.00 | - | |
| Hannah Valantine | Option exercise | Common Stock | 7,606 | $20.56 | $156K | |
| Hannah Valantine | Option exercise | Common Stock | 16,048 | $14.19 | $228K | |
| Hannah Valantine | Option exercise | Common Stock | 5,125 | $7.96 | $41K | |
| Hannah Valantine | Open-market sale | Common Stock | 28,679 | $36.14 | $1.04M | |
| Hannah Valantine | Open-market sale | Common Stock | 100 | $36.55 | $4K | |
| Hannah Valantine | Option exercise | Stock Option (Right to Buy) | 7,606 | $0.00 | - | |
| Hannah Valantine | Option exercise | Stock Option (Right to Buy) | 16,048 | $0.00 | - | |
| Hannah Valantine | Option exercise | Stock Option (Right to Buy) | 5,125 | $0.00 | - | |
| Grant or award | Common Stock | 1,746 | $0.00 | - | ||
| John Walter Hanna Jr. - Officer | Tax withholding / forfeiture | Common Stock | 8,511 | $29.25 | $249K | |
| Tax withholding / forfeiture | Common Stock | 997 | $29.25 | $29K | ||
| Jessica Meng - Officer | Tax withholding / forfeiture | Common Stock | 2,411 | $29.25 | $71K | |
| Keith Kennedy - Officer | Tax withholding / forfeiture | Common Stock | 2,930 | $29.25 | $86K | |
| John Walter Hanna Jr. - Officer | Open-market sale | Common Stock | 100 | $29.00 | $3K | |
| John Walter Hanna Jr. - Officer | Option exercise | Employee Stock Option (right to buy) | 13,618 | $0.00 | - | |
| John Walter Hanna Jr. - Officer | Option exercise | Employee Stock Option (right to buy) | 15,676 | $0.00 | - | |
| John Walter Hanna Jr. - Officer | Option exercise | Employee Stock Option (right to buy) | 100 | $0.00 | - | |
| John Walter Hanna Jr. - Officer | Option exercise | Employee Stock Option (right to buy) | 39,900 | $0.00 | - | |
| John Walter Hanna Jr. - Officer | Open-market sale | Common Stock | 39,900 | $29.24 | $1.17M | |
| John Walter Hanna Jr. - Officer | Option exercise | Common Stock | 706 | $8.20 | $6K | |
| John Walter Hanna Jr. - Officer | Option exercise | Common Stock | 13,618 | $8.20 | $112K | |
| John Walter Hanna Jr. - Officer | Option exercise | Common Stock | 15,676 | $8.20 | $129K | |
| John Walter Hanna Jr. - Officer | Option exercise | Common Stock | 100 | $8.20 | $820 | |
| John Walter Hanna Jr. - Officer | Option exercise | Common Stock | 39,900 | $8.20 | $327K | |
| John Walter Hanna Jr. - Officer | Option exercise | Employee Stock Option (right to buy) | 706 | $0.00 | - | |
| John Walter Hanna Jr. - Officer | Open-market sale | Common Stock | 17,683 | $24.03 | $425K | |
| Hannah Valantine | Open-market sale | Common Stock | 12,103 | $23.11 | $280K | |
| Hannah Valantine | Grant or award | Common Stock | 9,795 | $0.00 | - | |
| Grant or award | Common Stock | 9,795 | $0.00 | - | ||
| Richard Bryan Riggsbee | Grant or award | Common Stock | 9,795 | $0.00 | - | |
| Fred E. Cohen | Grant or award | Common Stock | 9,795 | $0.00 | - | |
| Suresh Gunasekaran | Grant or award | Common Stock | 9,795 | $0.00 | - | |
| Grant or award | Common Stock | 9,795 | $0.00 | - | ||
| Grant or award | Common Stock | 9,795 | $0.00 | - | ||
| John Walter Hanna Jr. - Officer | Open-market sale | Common Stock | 21,998 | $24.02 | $528K | |
| Tax withholding / forfeiture | Common Stock | 1,292 | $21.95 | $28K | ||
| John Walter Hanna Jr. - Officer | Open-market sale | Common Stock | 4,835 | $24.00 | $116K | |
| Arthur A. Torres | Open-market sale | Common Stock | 4,086 | $20.97 | $86K | |
| Arthur A. Torres | Open-market sale | Common Stock | 6,484 | $19.89 | $129K | |
| Open-market sale | Common Stock | 2,688 | $20.68 | $56K | ||
| Tax withholding / forfeiture | Common Stock | 2,873 | $21.50 | $62K | ||
| Keith Kennedy - Officer | Grant or award | Common Stock | 24,134 | $0.00 | - | |
| John Walter Hanna Jr. - Officer | Open-market sale | Common Stock | 10,282 | $21.12 | $217K | |
| John Walter Hanna Jr. - Officer | Tax withholding / forfeiture | Common Stock | 62,049 | $17.57 | $1.09M |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| PETER MAAG | Director | 9,122 | $423K | View on EDGAR | |
| PETER MAAG | Director | 7,000 | $317K | View on EDGAR | |
| PETER MAAG | Director | 7,000 | $330K | View on EDGAR |
CareDx, Inc. (CDNA) had 24 insider filings in the last 90 days, with the most recent on 2026-08-06. The full record for CDNA runs to 94 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of CDNA were filed in the last 90 days.
15 insider sales of CDNA were filed in the last 90 days, totaling $11.92M.
This page tracks CDNA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CDNA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.